Clinical trial 2026-526043-36-00 · advanced NSCLC
Oncology research
02 Nov 2026
2026-526043-36-00 — is «authorised» on CTIS (EU Clinical Trials Information System).
Clinical trial 2026-526043-36-00 (phase II) is «authorised» on CTIS (EU Clinical Trials Information System).
Condition: advanced NSCLC · Registered interventions: ivonescimab, Gemcitabine 100 mg/ml Concentrate for Solution for Infusion · Recorded dates (source): 2026-10-30.
Source: https://euclinicaltrials.eu/ctis-public/view/2026-526043-36-00